Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.

Geron Announces Positive Top-Line Results Trial Lower Risk MDS

This topic has 4 replies, 5 voices, and was last updated 1 year, 3 months ago by Robin Smith.

Viewing 5 posts - 1 through 5 (of 5 total)

Author

Posts
January 9, 2023 at 7:34 pm #59020

Eric King
Participant

Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS

Has anyone heard about this company or this trial?

https://www.geron.com/

Haven’t seen much about low risk MDS.

January 9, 2023 at 8:17 pm #59022
Marie Yeager
Participant
I just saw this 2 days ago. My husband has Lower Risk MDS that is progressing, so we’ve been following. On track to be FDA approved in 2024 I think.Hoping this is discussed on the upcoming webinar in February. https://www.onclive.com/view/imetelstat-provides-durable-transfusion-independence-in-lower-risk-mds
- This reply was modified 1 year, 3 months ago by Marie Yeager.
January 10, 2023 at 11:53 am #59024

Robin Vaught
Participant

My Dr. just told me about this Friday. I’ve been reading as much as I can, I’m low risk R/A this could be a God send.

January 12, 2023 at 3:54 pm #59126

Jimmy Greenhut
Participant

It’s worked for me Imetelstat. Enrolled @ Moffitt phase 3 trial. I was 7 pints a month. It’s been
6 weeks now no transfusion. 1st time in a couple yrs. 10.2 HGB. FDA will fast track to make it available for others 2024

January 13, 2023 at 12:01 pm #59127

Robin Smith
Participant

Had not heard of this. Thank you so much for sharing!!

Fantastic news Jimmy!! Thanking you as well for sharing this wonderful news!
Author

Posts